David Suhy
Fondateur chez Earli, Inc.
Profil
David Suhy is the founder of Earli, Inc. Prior to founding Earli, he worked as the Chief Scientific Officer at Benitec Biopharma Ltd.
from 2015 to 2018.
Before that, he was the Director of Research & Development at Tacere Therapeutics, Inc. from 2008 to 2012.
He also worked as an Associate Director of Research & Development at Takara Bio USA, Inc. Dr. Suhy received his undergraduate degree from the University of Pittsburgh and his doctorate from Northwestern University.
Postes actifs de David Suhy
| Sociétés | Poste | Début |
|---|---|---|
Earli, Inc.
 Earli, Inc. Medical SpecialtiesHealth Technology Earli, Inc. is a biotechnology company located in a biotech hub. The American company's mission is to make cancer a benign experience by catching and curing it early. Earli focuses on making cancer detectable and treatable at early stages through its novel "synthetic biopsies." By forcing cancer cells to produce synthetic biomarkers, they become highly detectable and localizable in a PET scanner, allowing for targeted treatment. Earli uses biology to force production of the synthetic biopsy, enabling massive signal amplification. The company was founded by Cyriac R. Roeding, David Suhy, and Sam Gambhir, with Cyriac R. Roeding serving as CEO since incorporation. | Fondateur | - |
Anciens postes connus de David Suhy
| Sociétés | Poste | Fin |
|---|---|---|
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Directeur Technique/Scientifique/R&D | 22/06/2018 |
Tacere Therapeutics, Inc.
 Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Corporate Officer/Principal | 01/10/2012 |
Takara Bio USA, Inc.
 Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Corporate Officer/Principal | - |
Formation de David Suhy
| University of Pittsburgh | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Takara Bio USA, Inc.
Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Health Services |
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Health Technology |
Earli, Inc.
Earli, Inc. Medical SpecialtiesHealth Technology Earli, Inc. is a biotechnology company located in a biotech hub. The American company's mission is to make cancer a benign experience by catching and curing it early. Earli focuses on making cancer detectable and treatable at early stages through its novel "synthetic biopsies." By forcing cancer cells to produce synthetic biomarkers, they become highly detectable and localizable in a PET scanner, allowing for targeted treatment. Earli uses biology to force production of the synthetic biopsy, enabling massive signal amplification. The company was founded by Cyriac R. Roeding, David Suhy, and Sam Gambhir, with Cyriac R. Roeding serving as CEO since incorporation. | Health Technology |